Ramesh C. Gupta

Active 1975–2025

Also published as
Ramesh C. Gupta.
171
Papers
25,926
Citations
91
h-index
157
i10-index

Citations

Citations per year for Ramesh C. Gupta1977: 2 citations1978: 1 citations1979: 3 citations1980: 10 citations1981: 20 citations1982: 20 citations1983: 27 citations1984: 52 citations1985: 88 citations1986: 65 citations1987: 39 citations1988: 75 citations1989: 46 citations1990: 72 citations1991: 53 citations1992: 49 citations1993: 51 citations1994: 69 citations1995: 49 citations1996: 85 citations1997: 58 citations1998: 66 citations1999: 82 citations2000: 104 citations2001: 88 citations2002: 95 citations2003: 94 citations2004: 78 citations2005: 74 citations2006: 83 citations2007: 72 citations2008: 63 citations2009: 93 citations2010: 77 citations2011: 79 citations2012: 100 citations2013: 115 citations2014: 140 citations2015: 116 citations2016: 165 citations2017: 229 citations2018: 247 citations2019: 630 citations2020: 867 citations2021: 902 citations2022: 777 citations2023: 674 citations2024: 834 citations2025: 438 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,280 citing papers, 22.8% of this breakdownChina: 1,241 citing papers, 12.4% of this breakdownGermany: 508 citing papers, 5.1% of this breakdownIndia: 490 citing papers, 4.9% of this breakdownItaly: 455 citing papers, 4.6% of this breakdownUnited Kingdom: 423 citing papers, 4.2% of this breakdownIran: 278 citing papers, 2.8% of this breakdownFrance: 255 citing papers, 2.6% of this breakdownCanada: 253 citing papers, 2.5% of this breakdownSpain: 225 citing papers, 2.2% of this breakdownJapan: 211 citing papers, 2.1% of this breakdownSouth Korea: 206 citing papers, 2.1% of this breakdown
0%22.8%Other 31.7%

Fields

  • Biochemistry, Genetics and Molecular Biology50.6%
  • Medicine22.5%
  • Agricultural and Biological Sciences4.2%
  • Environmental Science4.1%
  • Mathematics3.9%
  • Immunology and Microbiology2.5%
  • Other12.2%

Topics

  • Extracellular vesicles in disease8.9%
  • MicroRNA in disease regulation5.9%
  • RNA Interference and Gene Delivery3.5%
  • RNA and protein synthesis mechanisms2.3%
  • RNA modifications and cancer2%
  • Genomics and Phylogenetic Studies1.8%
  • Other75.6%

Coauthors

All papers

Open in search
  1. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magdalena J. Lorenowicz, Sai Kiang Lim, Jan Lötvall, Casey A. Maguire, Antonio Marcilla, Irina Nazarenko, Takahiro Ochiya, Tushar Patel, Shona Pedersen, Gabriella Pòcsfalvi, Stefano Pluchino, Peter J. Quesenberry, Ilona Reischl, Francisco J. Rivera, Ralf Sanzenbacher, Katharina Schallmoser, Ineke Slaper‐Cortenbach, Dirk Strunk, Torsten Tonn, Pieter Vader, Bas W. M. van Balkom, Marca H. M. Wauben, Samir EL Andaloussi, Clotilde Théry, Eva Rohde, Bernd Giebel - Journal of Extracellular Vesicles 2015 cited by 1,514

  2. Bovine milk-derived exosomes for drug delivery

    Authors: , , , - Cancer Letters 2015 cited by 932

  3. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory

    Authors: , , , - Frontiers in Veterinary Science 2019 cited by 716

  4. Milk-derived exosomes for oral delivery of paclitaxel

    Authors: , , , , , , , , , , - Nanomedicine Nanotechnology Biology and Medicine 2017 cited by 537

  5. Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin

    Authors: , , , , - The AAPS Journal 2017 cited by 300

  6. Milk exosomes - Natural nanoparticles for siRNA delivery

    Authors: , , , , , , - Cancer Letters 2019 cited by 316

  7. Exosomal formulation enhances therapeutic response of celastrol against lung cancer

    Authors: , , , , , , - Experimental and Molecular Pathology 2016 cited by 267

  8. Exosomal formulation of anthocyanidins against multiple cancer types

    Authors: , , , , , , , , - Cancer Letters 2017 cited by 224

  9. Exosome-mediated delivery of RNA and DNA for gene therapy

    Authors: , , , , , , , , , , - Cancer Letters 2021 cited by 136

  10. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure

    Authors: , , , , , - Circulation Heart Failure 2016 cited by 210

  11. Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes

    Authors: , , , - Cancer Letters 2023 cited by 63

  12. Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application

    Authors: , , , , , , , - Cancers 2022 cited by 83

  13. Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide

    Authors: , , , , - Cardiovascular Drugs and Therapy 2018 cited by 88

  14. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rajat K. Dhar, Eva Dokoupilová, Rita M. Egan, Andrea Everding, E. Galíndez, Mark C. Genovese, David H. Goddard, Alice B. Gottlieb, Philippe Goupille, Robert Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu‐Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Klein, Mariusz Korkosz, Roshan Kotha, Joel M. Kremer, C Lue, José Luís Marenco de la Fuente, Helena Marzo‐Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama Nandagudi, Peter Nash, Antonio Fernández‐Nebro, C. Michael Neuwelt, Ana‐Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria Rell‐Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen‐Fang Tsai, Anthony Turkiewicz, L. Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielińska - The Lancet 2017 cited by 405

  15. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer

    Authors: , , , , , , - Food & Function 2017 cited by 175

  16. Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes

    Authors: , , , , , , , , , - Cancers 2021 cited by 95

  17. Modeling failure time data by lehman alternatives

    Authors: , , - Communication in Statistics- Theory and Methods 1998 cited by 819

  18. Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells

    Authors: , , , , , , - Cancer Letters 2012 cited by 162

  19. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications

    Authors: , , , , , - Diabetology & Metabolic Syndrome 2017 cited by 227

  20. Nutraceuticals in Veterinary Medicine

    Authors: , , - 2019 cited by 155

  21. Milk exosomes: A biogenic nanocarrier for small molecules and macromolecules to combat cancer

    Authors: , , , - American Journal of Reproductive Immunology 2020 cited by 64

  22. Exosome-based approaches in the management of Alzheimer’s disease

    Authors: , , , , - Neuroscience & Biobehavioral Reviews 2022 cited by 37

  23. Microbe-based therapies for colorectal cancer: Advantages and limitations

    Authors: , , , , , , - Seminars in Cancer Biology 2021 cited by 73

  24. Exosomes as an Emerging Plasmid Delivery Vehicle for Gene Therapy

    Authors: , , , - Pharmaceutics 2023 cited by 28